Many health and wellness stocks have faced challenges in recent years as GLP-1 weight-loss drugs like Ozempic and Wegovy ...

With new leadership and a Nasdaq relisting plan, the iconic brand is betting on women’s health and weight loss drugs to stage a comeback.

In the Age of Ozempic, ... Just two months after filing for bankruptcy, ... but her move to WeightWatchers—a legacy weight-loss empire that has been around since 1961—is a step in a ...

WeightWatchers said its forthcoming menopause programme — which will deliver “tailored nutritional and behavioural strategies” — is a “strategic move to address a broader gap in healthcare”.